SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

(2017) Aidin Rawshani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sirt1 carboxyl-domain is an ATP-repressible domain that is transferrable to other proteins

(2017) Hyeog Kang et al.   Nature Communications

Resveratrol and Cardiovascular Diseases

(2016) Dominique Bonnefont-Rousselot   Nutrients

Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway

(2015) Tongshuai Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise

(2015) Joel D. Schilling   ANTIOXIDANTS & REDOX SIGNALING

Mitochondrial Dynamics in Diabetic Cardiomyopathy

(2015) Chad A. Galloway et al.   ANTIOXIDANTS & REDOX SIGNALING

Diabetic Cardiomyopathy and the Role of Mitochondrial Dysfunction: Novel Insights, Mechanisms, and Therapeutic Strategies

(2015) Miguel A. Aon et al.   ANTIOXIDANTS & REDOX SIGNALING

Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets

(2015) Miranda M. Sung et al.   ANTIOXIDANTS & REDOX SIGNALING

Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart

(2015) Edwin J. Vazquez et al.   CARDIOVASCULAR RESEARCH

Diabetic Cardiomyopathy: Catabolism Driving Metabolism

(2015) Z. V. Wang et al.   CIRCULATION

Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor  

(2015) F. Liu et al.   CIRCULATION

Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type-1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy

(2015) Rui Ni et al.   DIABETES

SIRT1 attenuates high glucose-induced insulin resistance via reducing mitochondrial dysfunction in skeletal muscle cells

(2015) Hao-Hao Zhang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism

(2015) Rong Guo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3

(2015) Pankaj K. Bagul et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK

(2015) Shuang Guo et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network

(2015) Clémence D Côté et al.   NATURE MEDICINE

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

(2015) Guanghong Jia et al.   Nature Reviews Endocrinology

Inhibition of JNK Phosphorylation by a Novel Curcumin Analog Prevents High Glucose-Induced Inflammation and Apoptosis in Cardiomyocytes and the Development of Diabetic Cardiomyopathy

(2014) Y. Pan et al.   DIABETES

Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways

(2014) Karina Huynh et al.   PHARMACOLOGY & THERAPEUTICS

Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes via a cAMP/PKA/Rho-Dependent Mechanism

(2013) D. Wang et al.   DIABETES

Protective Effects of Low-Frequency Magnetic Fields on Cardiomyocytes from Ischemia Reperfusion InjuryviaROS and NO/ONOO−

(2013) Sai Ma et al.   Oxidative Medicine and Cellular Longevity

SIRT1 is dispensable for function of hematopoietic stem cells in adult mice

(2012) V. Leko et al.   BLOOD

Resveratrol Rescues SIRT1-Dependent Adult Stem Cell Decline and Alleviates Progeroid Features in Laminopathy-Based Progeria

(2012) Baohua Liu et al.   Cell Metabolism

Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in mice

(2012) Pavan K. Battiprolu et al.   JOURNAL OF CLINICAL INVESTIGATION

Are sirtuins viable targets for improving healthspan and lifespan?

(2012) Joseph A. Baur et al.   NATURE REVIEWS DRUG DISCOVERY

Mitochondrial dysfunction in diabetic cardiomyopathy

(2011) Jennifer G. Duncan   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Diagnosis and Classification of Diabetes Mellitus

(2011)   DIABETES CARE

IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

(2011) David R. Whiting et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin

(2010) Jiung-Pang Huang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease

(2010) Jun Ren et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy

(2009) M. Sulaiman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Diabetic cardiomyopathy-associated dysfunction in spatially distinct mitochondrial subpopulations

(2008) Erinne R. Dabkowski et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY